Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection
Harmony L. Tyner, Jefferey L Burgess, Lauren Grant, Manjusha Gaglani, Jennifer L. Kuntz, Allison L. Naleway, Natalie J. Thornburg, Alberto J. Caban-Martinez, Sarang K. Yoon, Meghan K. Herring, Shawn C. Beitel, Lenee Blanton, Janko Nikolich-Zugich, Matthew S. Thiese, Jessica Flores Pleasants, Ashley L. Fowlkes, Karen Lutrick, Kayan Dunnigan, Young M.Yoo, Spencer Rose, Holly Groom, Jennifer Meece, Meredith G. Wesley, Natasha Schaefer-Solle, Paola Louzado-Feliciano, Laura J. Edwards, Lauren E. W. Olsho, Mark G. Thompson
doi: https://doi.org/10.1101/2021.10.20.21265171
